Although administration of SOD mimetic tempol in pregnancy has been reported to reduce BP in spontaneously hypertensive rat offspring [148], none of the SOD mimetics have been approved in models of MetS programming to date. This evidence concerns the gene SOD1 and metabolic syndrome.